The detection of specific metabolites (Lac, Ala, and Lip) at TE = 144 ms for the HISE and PRESS SVS scans, respectivelya
No. | Sex | Age (yr) | Pathologic Diagnosis | HISE | PRESS | ||||
---|---|---|---|---|---|---|---|---|---|
Lac | Ala | Lip | Lac | Ala | Lip | ||||
Case 1 | F | 71 | Acoustic neuroma | + | − | + | − | − | + |
Case 2 | M | 47 | Acoustic neuroma | + | − | − | − | − | − |
Case 3 | M | 52 | Metastases (lung origin) | + | ? | + | − | − | + |
Case 4 | M | 58 | Metastases (gastrointestinal origin) | + | − | + | − | − | + |
Case 5 | M | 61 | Non-Hodgkin lymphoma | + | − | + | − | − | + |
Case 6 | M | 66 | Meningioma, WHO I | + | + | − | − | − | − |
Case 7 | F | 52 | Meningioma, WHO I | + | + | − | − | − | − |
Case 8 | F | 67 | Meningioma, WHO I | + | ? | − | + | − | − |
Case 9 | F | 43 | Meningioma, WHO II | + | + | − | − | + | − |
Case 10 | M | 52 | Meningioma, WHO I | + | ? | + | − | − | + |
Case 11 | F | 34 | Meningioma, WHO I | + | + | − | − | ? | − |
Case 12 | F | 56 | Meningioma, WHO I | − | − | + | − | − | + |
Case 13 | F | 50 | Meningioma, WHO I | + | + | − | − | − | − |
Case 14 | F | 58 | Meningioma, WHO I | − | + | + | − | ? | + |
Case 15 | F | 42 | Oligodendroglioma, WHO III | + | − | − | − | − | − |
Case 16 | F | 49 | Oligodendroglioma, WHO II | + | − | − | − | − | − |
Case 17 | F | 35 | GBM, WHO IV | + | − | − | − | − | + |
Case 18 | M | 45 | GBM, WHO IV | + | ? | + | − | − | + |
Case 19 | F | 64 | GBM, WHO IV | + | ? | + | + | − | + |
Case 20 | F | 67 | GBM, WHO IV | + | − | − | − | − | + |
Case 21 | F | 70 | GBM, WHO IV | + | ? | + | − | − | + |
Case 22 | M | 66 | GBM, WHO IV | + | − | − | + | − | + |
Case 23 | F | 69 | GBM, WHO IV | + | − | + | + | − | + |
Note:—F indicates female; M, male; WHO, World Health Organization; GBM, glioblastoma.
↵a The plus sign represents the detection of strong signal peaks; the question mark represents the presence of faint or inconspicuous signal peaks; and the minus sign represents the almost undetectable signal peaks.